The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
WCLC 2024 | The importance of diversity and inclusion in clinical trial enrolment
Matthew Lee, MD, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, highlights the need for increased diversity and inclusion in lung cancer clinical trials. A more diverse and inclusive patient cohort will ultimately result in findings that can be translated into the clinic and reflect real-world outcomes. This interview took place at the 2024 World Conference on Lung Cancer (WCLC) in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
